Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride

EU orphan designation number: EU/3/13/1122   
Active ingredient: R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride
Indication: Treatment of Duchenne muscular dystrophy
Sponsor: N-GENE Kutatási és Fejlesztési Kft
Szent István krt. 18, H-1137 Budapest, Magyarország

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/05/2013 Centralised Orphan - Designation EMA/OD/183/12 (2013)2559 of 26/04/2013